Related Experiment Video
Updated: Jul 20, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Cervical cancer: what should we tell women about screening?
Jennifer Tiffen1, Suzanne M Mahon
1Department of Medical-Surgical Nursing, University of Illinois-Chicago, USA. jtiffen@uic.edu
Abstract:
Cervical cancer is the second most common cancer among women worldwide, with significantly higher rates in developing areas, especially in Africa, the Caribbean, and Latin America (Parkin, Bray, Ferlay, & Pisani, 2005). In contrast, incidence and mortality rates of cervical cancer in the United States have declined significantly among women of all ethnic and racial groups; it is not among the top 10 leading causes of new cancer cases in women (American Cancer Society [ACS], 2006b; Edwards et al.,2005).
Related Concept Videos
Preventive Healthcare Services
Cancer Prevention
Some...
Cancer Prevention
Some...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Disorders of the Female Reproductive System
